Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Announcing the new Tapestri Solution for Solid Tumor Oncology Research. Learn More
X
Scientific presentation

Single-cell DNA-Seq publication roundup: what did they uncover at MD Anderson Cancer Center, UCSF, Memorial Sloan Kettering, and Stanford Medicine?


Kelly Kaihara, PhD
Description

Single-cell sequencing methods have enabled multi-modal characterization of tumor heterogeneity to yield novel insights into tumor evolution, therapeutic response, and resistance in hematological disorders. Dr. Kelly Kaihara, from Mission Bio, reviews recent publications from MD Anderson Cancer Center, UCSF, Memorial Sloan Kettering, and Stanford Medicine that use the Mission Bio Tapestri Platform for single-cell analysis. See how researchers are using this groundbreaking technology to study single-cell multi-omics of DNA and Protein for the first time in a high-throughput fashion.



VIEW


Scientific presentation
CHIP’ing away at somatic mosaicism — Diving into the promises and challenges of characterizing clonal hematopoiesis of indeterminate potential
Ross Levine, MD
Kelly Bolton, MD, PhD
Jyoti Nangalia, MD, PhD
Todd Druley, MD, PhD
(2022)
Scientific presentation
Meet the Authors: Clonal Heterogeneity in Acute Lymphoblastic Leukemia at Diagnosis and During Chemo Treatment
Jan Cools, PhD, VIB Center for Cancer Biology
(2022)
Scientific presentation
AMP 2021 Corporate Workshop: Single-cell DNA and multi-omics strategies for untangling therapy-resistant mechanisms in oncology
John Lee, M.D., Ph.D., Fred Hutchinson Cancer Research Center & Julia Gouffon, Ph.D., Mission Bio
Association for Molecular Pathology 2021 Digital Experience (2021)
Scientific presentation
Do More Single Cell with Less – Tapestri Platform Expansion for Hematologic Malignancy Research
Koichi Takahashi, MD, PhD, MD Anderson Cancer Center & Jim Flynn, PhD, Mission Bio
(2021)
REQUEST QUOTE